Export restrictions lifted on HCQ APIs, formulations by Government
The export restrictions has been lifted by the government on active pharmaceutical ingredients (API) and formulations of hydroxychloroquine (HCQ). “Department of Pharmaceuticals has approved the lifting of ban on export…
‘Aatma Nirbhar Bharat’ is some Music to Domestic Medical Device Industry
New Delhi: At long last, ‘Make in India’ music has lyrics in it for domestic medical device industry. The modification in public procurement norms has it in glee and going…
Guidelines issued by DoP for bulk drug parks
A brief guidelines for bulk drug parks and detailed guidelines will be released soon by The Department of Pharmaceuticals (DoP), under the Ministry of Chemicals and Fertilisers, the Government of…
NPPA: Retail prices of 40 formulations fixed
The National Pharmaceutical Pricing Authority (NPPA) has fixed prices for 40 different formulations produced by 12 manufacturers which applied for the same by submitting Form-I for price fixation/revision as stipulated…
DCGI granted nod to SunPharma for clinical trial with Nafamostat
The Drugs Controller General of India (DCGI) gave green signal to Sun Pharmaceutical Industries to conduct clinical trial with Nafamostat Mesilate for the treatment of COVID-19 patients. Nafamostat has been…
NPPA: Cipla to improve the supply of tocilizumab injection
The pharmaceutical major Cipla Ltd has been directed by the National Pharmaceutical Pricing Authority (NPPA) to improve the supply and demand of tocilizumab injection in Gujarat useful in treatment of…
NPPA: Manufacturers of N-95 masks directed to maintain parity in prices for non-govt procurements to curb black marketing
Manufacturers, importers and suppliers of N-95 has been directed by the National Pharmaceutical Pricing Authority (NPPA) for maintaining parity in prices for non-government procurements for the purpose of making available…
DoP proposes to oversee drug regulator
As the government plans a major overhaul of the country’s drug authority, the Department of Pharmaceuticals (DoP) has proposed to oversee Central Drugs Standard Control Organisation (CDSCO) to be transferred…
COVID-19: DCGI approved NovaLead Pharma to conduct clinical
The Drugs Controller General of India (DCGI) has granted approval to NovaLead Pharma for conducting of phase III clinical trials for its repurposed drug discovery for treatemnt of moderate COVID-19…
CDSCO observed shortage of 15 drugs
A letter has been issued by the Central Drugs Standard Control Organisation (CDSCO) to all drug manufacturers associations giving an information about the low supply of 15 essential drugs which…
